These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 30537561
41. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial. Demoly P, Emminger W, Rehm D, Backer V, Tommerup L, Kleine-Tebbe J. J Allergy Clin Immunol; 2016 Feb; 137(2):444-451.e8. PubMed ID: 26292778 [Abstract] [Full Text] [Related]
47. Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients. Nony E, Bouley J, Le Mignon M, Lemoine P, Jain K, Horiot S, Mascarell L, Pallardy M, Vincentelli R, Leone P, Roussel A, Batard T, Abiteboul K, Robin B, de Beaumont O, Arvidsson M, Rak S, Moingeon P. Allergy; 2015 Jul; 70(7):795-804. PubMed ID: 25846209 [Abstract] [Full Text] [Related]
48. Safety Review of 5-Grass Pollen Tablet from Pooled Data of Clinical Trials. Casale TB, Cox LS, Wahn U, Golden DBK, Bons B, Didier A. J Allergy Clin Immunol Pract; 2017 Jul; 5(6):1717-1727.e1. PubMed ID: 28734858 [Abstract] [Full Text] [Related]
49. Formation of IgE-Allergen-CD23 Complex Changes in Children Treated with Subcutaneous Immunotherapy for Japanese Cedar Pollinosis. Asaumi T, Sato S, Yanagida N, Matsuhara H, Kobayashi S, Fukano C, Ohashi-Doi K, Ebisawa M. Int Arch Allergy Immunol; 2021 Jul; 182(3):190-194. PubMed ID: 33032294 [Abstract] [Full Text] [Related]
50. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE. Cox LS, Casale TB, Nayak AS, Bernstein DI, Creticos PS, Ambroisine L, Melac M, Zeldin RK. J Allergy Clin Immunol; 2012 Dec; 130(6):1327-34.e1. PubMed ID: 23122534 [Abstract] [Full Text] [Related]
51. Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study. Pfaar O, Richter HG, Klimek L, Sieber J, Hadler M, Karagiannis E. Biomed Res Int; 2015 Dec; 2015():584291. PubMed ID: 26351635 [Abstract] [Full Text] [Related]
56. Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial. Maloney J, Bernstein DI, Nelson H, Creticos P, Hébert J, Noonan M, Skoner D, Zhou Y, Kaur A, Nolte H. Ann Allergy Asthma Immunol; 2014 Feb; 112(2):146-153.e2. PubMed ID: 24468255 [Abstract] [Full Text] [Related]
59. [Enhanced Clinical Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis in the Second Year of Treatment]. Yuta A, Ogawa Y, Suzuki Y, Arikata M, Kozaki H, Shimizu T, Ohta N. Nihon Jibiinkoka Gakkai Kaiho; 2017 Jan; 120(1):44-51. PubMed ID: 30035467 [Abstract] [Full Text] [Related]
60. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH CEDAR POLLEN IN A YEAR OF MASSIVE CEDAR POLLEN DISPERSAL AND ITS EFFECT ON JAPANESE CYPRESS POLLINOSIS]. Yuta A, Ogawa Y, Kozaki H, Shimizu T. Arerugi; 2023 Jan; 72(10):1230-1239. PubMed ID: 38092399 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]